Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NasdaqGS:AMGN
Amgen
|
310.15 | -11.6% | -2.74% | 166,375.22 | 2.88% | 5.31% |
|
NYSE:PFE
Pfizer
|
28.01 | 10.84% | 41.72% | 158,721.27 | 5.96% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
94.33 | 12.8% | 30.73% | 117,784.75 | 4.04% | 8.19% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
973.80 | -28.98% | -22.93% | 105,058.9 | 0% | 13.9% |
|
ASX:CSL
CSL
|
279.18 | 22.87% | 43.8% | 134,914.5 | 1.29% | 7.18% |
|
TSE:4568
Daiichi Sankyo Company
|
5385.00 | 0% | 0% | 10,322,749.31 | 1.15% | 0% |
|
NasdaqGS:MRNA
Moderna
|
117.31 | -,112.14% | -,108.38% | 44,957.85 | 0% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4129.00 | 0% | 0% | 6,478,127.87 | 4.75% | 0% |
|
NasdaqGS:BIIB
Biogen
|
221.50 | -11.75% | 3.9% | 32,249.71 | 0% | -10.89% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
150.47 | 0% | 0% | 19,033.22 | 0% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
81.03 | 142.2% | 221.62% | 15,385.96 | 0% | 32.46% |
|
NasdaqGS:SRPT
Sarepta Therapeutics
|
131.82 | 0% | 0% | 12,505.49 | 0% | 0% |
|
NasdaqGS:INCY
Incyte
|
53.06 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
NasdaqGS:JAZZ
Jazz Pharmaceuticals
|
109.63 | 53.71% | 67.56% | 7,131.04 | 0% | 5.95% |
|
NasdaqGS:EXEL
Exelixis
|
21.37 | 39.15% | 69.39% | 6,338.53 | 0% | -8.84% |
|
NasdaqGM:NTLA
Intellia Therapeutics
|
24.46 | 0% | 0% | 2,358.89 | 0% | 0% |
|
NasdaqGS:DYN
Dyne Therapeutics
|
26.00 | 0% | 0% | 2,267.58 | 0% | 0% |
|
NasdaqGS:DCPH
Deciphera Pharmaceuticals
|
25.36 | 0% | 0% | 2,085.25 | 0% | 0% |
|
TSE:4516
Nippon Shinyaku
|
4423.00 | 0% | 0% | 297,901.34 | 2.81% | 0% |
|
NasdaqGS:BCRX
BioCryst Pharmaceuticals
|
5.32 | 0% | 0% | 1,087.36 | 0% | 0% |
